Century Therapeutics, Inc. (IPSC) (CIK 0001850119) (IPSC)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Feb. 17, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Feb. 17, 2026 | CORRESP | Neutral/Informational | High | Century Therapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, which was filed on February 5, 2026. Th… | Read Filing EDGAR |
| Feb. 17, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated February 17, 2026, informs Brent Pfeiffenberger, CEO of Century Therapeutics, Inc., that the SEC has not reviewed and will not review the company's re… | Read Filing EDGAR |
| Jan. 7, 2026 | CORRESP | Neutral/Informational | Moderate | Century Therapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on July 10, 2025. The … | Read Filing EDGAR |